A Phase I, Open Label, Dose Escalation Study to Evaluate the Safety and Immune Activation of Adv-GM-CAIX Transduced Dendritic Cells in Patients with Metastatic Kidney Cancer - 100098

Spotlight
Video

A Phase I, Open Label, Dose Escalation Study to Evaluate the Safety and Immune Activation of Adv-GM-CAIX Transduced Dendritic Cells in Patients with Metastatic Kidney Cancer

kidneycancer has 449 videos Subscribe Here

Loading........
Description: ALEXANDRA DRAKAKI, MD, PHD UNIVERSITY OF CALIFORNIA LOS ANGELES gives an overview of A Phase I, Open Label, Dose Escalation Study to Evaluate the Safety and Immune Activation of Adv-GM-CAIX Transduced Dendritic Cells in Patients with Metastatic Kidney Cancer at the 2017 Kidney Cancer Association symposium in Miami, FL.

Shared By : kidneycancer
Posted on : 11/07/17
Added : 5 months ago
Category : Kidney Cancer



Recommended

Nothing found.